Toward Effective Probiotics for Autism and Other Neurodevelopmental Disorders
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Hsaio and colleagues link gut microbes to autism spectrum disorders (ASD) in a mouse model. They show that ASD symptoms are triggered by compositional and structural shifts of microbes and associated metabolites, but symptoms are relieved by a B. fragilis probiotic. Thus probiotics may provide therapeutic strategies for mental disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888 · cited 1×
“…conditions, including depression and schizophrenia (Knight et al., 2007), and several reports indicate that probiotics can treat anxiety and posttraumatic stress disorder (PTSD) in mouse models, including one model that requires an intact vagus nerve for gutbrain signaling (Bravo et al., 2011).”
BackgroundThe impact of the gut microbiota on human health: an integrative view
Clemente, J. C., Ursell, L. K., Parfrey, L. W., & Knight, R. (2012) · Cell · doi:10.1016/j.cell.2012.01.035 · Cited by 3,710
Self-citationHsiao, E. Y., McBride, S. W., Hsien, S., Sharon, G., Hyde, E. R., McCue, T., Codelli, J. A., Chow, J., Reisman, S. E., Petrosino, J. F., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.024 · Cited by 3,283
Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5
Vijay-Kumar, M., Aitken, J. D., Carvalho, F. A., Cullender, T. C., Mwangi, S., Srinivasan, S., Sitaraman, S. V., Knight, R., Ley, R. E., & Gewirtz, A. T. (2010) · Science · doi:10.1126/science.1179721 · Cited by 2,068 · cited 1×
“…TLR5 knockout mice can become obese because an altered microbial community, instead of affectingmetabolic efficiency, increases its appetite (Vijay-Kumar et al., 2010), or in a mouse model of multiple sclerosis, demyelination only occurs in the context of the gut microbiota (Lee et al.,…”
BackgroundSelf-citationProinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis
Lee, Y. K., Menezes, J. S., Umesaki, Y., & Mazmanian, S. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000082107 · Cited by 1,323 · cited 1×
“…can become obese because an altered microbial community, instead of affectingmetabolic efficiency, increases its appetite (Vijay-Kumar et al., 2010), or in a mouse model of multiple sclerosis, demyelination only occurs in the context of the gut microbiota (Lee et al., 2011, Berer et al., 2011).”
BackgroundCommensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination
Berer, K., Mues, M., Koutrolos, M., Rasbi, Z. A., Boziki, M., Johner, C., Wekerle, H., & Krishnamoorthy, G. (2011) · Nature · doi:10.1038/nature10554 · Cited by 1,251
Consumption of fermented milk product with probiotic modulates brain activity
Tillisch, K., Labus, J., Kilpatrick, L., Jiang, Z., Stains, J., Ebrat, B., Guyonnet, D., Legrain–Raspaud, S., Trotin, B., Naliboff, B., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.043 · Cited by 1,192 · cited 1×
“In addition, microbial impacts on neurology are also evident, including anxiety and sociability in mice (Collins et al., 2013) and changing emotions in humans who received fermented milk with probiotics (Tillisch et al., 2013).”
BackgroundReduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children
Kang, D.-W., Park, J. G., Ilhan, Z. E., Wallstrom, G., LaBaer, J., Adams, J. B., & Krajmalnik-Brown, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068322 · Cited by 976 · cited 1×
“Although current literature regarding microbiota associated with ASD patients is limited and contradictory, there is evidence that ASD patients lack certain beneficial bacteria in their gut, e.g., Prevotella (Kang et al., 2013).”
BackgroundSelf-citationUrinary p-cresol in autism spectrum disorder
Persico, A. M., & Napolioni, V. (2013) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2012.09.002 · Cited by 189 · cited 1×
“Careful clinical trials will be needed in humans, as the effects of a given microbe and metabolite may differ in different species. human autism biomarker (Persico and Napolioni, 2013), although additional studies would be needed to confirm the generality of this finding.”
Background
Cited by
Gut/brain axis and the microbiota
Mayer, E. A., Tillisch, K., & Gupta, A. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76304 · Cited by 1,503
“22 and Figure 1), a range of effects of gut microbial modulation was reported on emotional behavior (38–43, 48, 68–70), learning and memory (42, 71, 72), social interactions (48, 58, 73), and ingestive behaviors (55).”
Kang, D.-W., Adams, J. B., Gregory, A. C., Borody, T., Chittick, L., Fasano, A., Khoruts, A., Geis, E., Maldonado, J., McDonough-Means, S., et al. (2017) · Microbiome · doi:10.1186/s40168-016-0225-7 · Cited by 1,391
Self-citationLuczynski, P., McVey Neufeld, K.-A., Oriach, C. S., Clarke, G., Dinan, T. G., & Cryan, J. F. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw020 · Cited by 632
“If the hypothesis that ASD has a microbial etiology proves correct, interventions targeting the gut microbiota such as diet and pro- and pre-biotics could provide safe and effective strategies for targeting neurodevelopmental disorders and their associated comorbidities (Gilbert et al., 2013; Mayer et al., 2014; Samps…”
BackgroundDiscovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches
Papadimitriou, K., Zoumpopoulou, G., Foligné, B., Alexandraki, V., Kazou, M., Pot, B., & Tsakalidou, E. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00058 · Cited by 384
Golubeva, A. V., Joyce, S. A., Moloney, G., Burokas, A., Sherwin, E., Arboleya, S., Flynn, I., Khochanskiy, D., Moya-Pérez, A., Peterson, V., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.09.020 · Cited by 364
The microbiota–gut–brain axis and neurodevelopmental disorders
Wang, Q., Yang, Q., & Liu, X. (2023) · Protein & Cell · doi:10.1093/procel/pwad026 · Cited by 355
Recent developments in understanding the role of the gut microbiota in brain health and disease
Sherwin, E., Dinan, T. G., & Cryan, J. F. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13416 · Cited by 338
A single-cell nanocoating of probiotics for enhanced amelioration of antibiotic-associated diarrhea
Pan, J., Gong, G., Wang, Q., Shang, J., He, Y., Catania, C., Birnbaum, D., Li, Y., Jia, Z., Zhang, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29672-z · Cited by 309
Altered brain-gut axis in autism: comorbidity or causative mechanisms
Mayer, E. A., Padua, D., & Tillisch, K. (2014) · BioEssays · doi:10.1002/bies.201400075 · Cited by 304
“[41] provide hope that novel gut microbiome-directed therapies, including those based on fecal microbial transplantation, may one day translate into the long sought after clinical improvements in a clearly defined subsets of patients [47].”
BackgroundDevelopment of the preterm infant gut microbiome: a research priority
Groer, M. W., Luciano, A. A., Dishaw, L. J., Ashmeade, T. L., Miller, E., & Gilbert, J. A. (2014) · Microbiome · doi:10.1186/2049-2618-2-38 · Cited by 285
Self-citationThe microbiota-gut-brain axis and its potential therapeutic role in autism spectrum disorder
Li, Q., & Zhou, J.-M. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.03.013 · Cited by 253
“4EPS, a uremic toxin and a possible urinary biomarker for autism, is the most significant metabolite to have been altered (Gilbert et al., 2013; Persico and Napolioni, 2013).”
Microbiome disturbances and autism spectrum disorders
Rosenfeld, C. S. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.063826 · Cited by 229
Programming Bugs: Microbiota and the Developmental Origins of Brain Health and Disease
Codagnone, M. G., Spichak, S., O’Mahony, S. M., O’Leary, O. F., Clarke, G., Stanton, C., Dinan, T. G., & Cryan, J. F. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.06.014 · Cited by 198
One health, fermented foods and gut microbiota
Bell, V., Ferrão, J., Pimentel, L., Pintado, M., & Fernandes, T. (2018) · Foods · doi:10.3390/foods7120195 · Cited by 188
“Despite disagreement among mental health practitioners and researchers pertaining to the aetiology, categorization, and medical care of several mental disorders [91], current research regarding fermented foods, the microbiome, and their effect on human health, particularly the global epidemic of mental health [92], de…”
BackgroundAnsari, F., Pourjafar, H., Tabrizi, A., & Homayouni, A. (2020) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201021666200107113812 · Cited by 170
Microbiome and nutrition in autism spectrum disorder: Current knowledge and research needs
Berding, K., & Donovan, S. M. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuw048 · Cited by 146
Liu, J., Liu, X., Xiong, X.-Q., Yang, T., Cui, T., Hou, N.-L., Lai, X., Liu, S., Guo, M., Liang, X.-H., et al. (2017) · BMC Microbiology · doi:10.1186/s12866-017-1096-1 · Cited by 115
“Social impairment was observed in germ-free mice [7] and treatment with the probiotic Bacteroides fragilis had a beneficial effect on autism behavior in an animal model of autism [8, 9].”
Lee, J., Yang, W., Hostetler, A., Schultz, N., Suckow, M. A., Stewart, K. L., Kim, D. D., & Kim, H. S. (2016) · BMC Microbiology · doi:10.1186/s12866-016-0686-7 · Cited by 107
The connection between microbiome and schizophrenia
Golofast, B., & Vales, K. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.12.011 · Cited by 92
Metadata
- Authors
- Gilbert, J. A., Krajmalnik-Brown, R., Porazinska, D. L., Weiss, S. J., & Knight, R.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 155
- Issue
- 7
- Pages
- 1446-1448
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W1969564659
- Cited by
- 121
- References
- 9
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.